Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
How It Is Studied Pharmacological characterization of sema at the GLP-1 receptor uses cAMP accumulation assays in GLP-1R-expressing HEK293 cells, radioligand competition binding with [125I]-GLP-1 or [3H]-exendin-4, and beta-arrestin recruitment BRET assays to determine binding affinity, efficacy, and biased agonism profiles
Unlike endogenous GLP-1, which is rapidly degraded in the body, GLP1-S has been structurally modified to resist enzymatic breakdown and remain active for longer durations
doi: 10.1186/s12885-020-06818-0 44
GLOW is typically 70 mg total: 10 mg BPC-157, 10 mg TB-4, 50 mg GHK-Cu
J.WalikonisR
N.GoodA
US$ 27.38
US$ 22.70
US$ 24.80
US$ 20.22
